Stephen is a Partner in the Media and Dispute Resolution teams. He also heads up SMB’s data protection unit.
He is a leading practitioner in media, commercial & film litigation, and in the regulatory field. He has specialist expertise in sports, regulatory matters, data protection, defamation & privacy as well as generally in investigative and forensic work. Before entering the law, Stephen gained a broad experience base as a journalist, a parliamentary researcher, and as an editor. which equips him with a wider perspective on the role of legal issues within the larger context of commerce and public opinion.
Chambers UK states that Stephen is “a phenomenal litigator”.” He has previously been described by the guide as “sharp as a whip…a tenacious litigator”. The Legal 500 recommended Stephen, whilst previous editions have hailed him as “one of the best forensic solicitors, with a great nose for a case” and credited his “particular expertise in forensic cases where evidence is of high importance”.
“Stephen Shotnes has excellent judgement, fights his client’s corner fiercely and is well respected.” Legal 500, 2021
“Tenacious, diligent and thinks outside of the box.” Legal 500, 2018
Legal 500, 2022
“Stephen Shotnes – a highly experienced litigator; one of the best (if not the best) tacticians in the game.”
“A good man to have in your corner.”
“Conscientious, robust, street-smart litigator.”
Legal 500, 2022
“No spot is too tight for Stephen to be able to find a way (or ways) out of it.”
This week Stephen Shotnes assisted the Bureau of Investigative Journalist’s investigation into eviction difficulties faced by residential tenants affected by the pandemic.Read more
SMB client The Bureau Of Investigative Journalism has raised further concerns about the inadequate way police forces deal with allegations of domestic abuse by police officers.Read more
The Bureau of Investigative Journalism has broken the story on Pfizer backing down on its demand that the South African government put up sovereign assets guaranteeing an indemnity against the cost of any future legal cases in return for supplies of the Pfizer vaccine.Read more